ATE2898T1 - Oxim-aether, ihre herstellung und diese enthaltende pharmazeutische praeparate. - Google Patents

Oxim-aether, ihre herstellung und diese enthaltende pharmazeutische praeparate.

Info

Publication number
ATE2898T1
ATE2898T1 AT79200416T AT79200416T ATE2898T1 AT E2898 T1 ATE2898 T1 AT E2898T1 AT 79200416 T AT79200416 T AT 79200416T AT 79200416 T AT79200416 T AT 79200416T AT E2898 T1 ATE2898 T1 AT E2898T1
Authority
AT
Austria
Prior art keywords
oxime
aether
preparation
pharmaceutical preparations
preparations containing
Prior art date
Application number
AT79200416T
Other languages
English (en)
Inventor
Jacob Adriaan Dr. Van Zorge
Original Assignee
Acf Chemiefarma Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acf Chemiefarma Nv filed Critical Acf Chemiefarma Nv
Application granted granted Critical
Publication of ATE2898T1 publication Critical patent/ATE2898T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT79200416T 1978-07-25 1979-07-24 Oxim-aether, ihre herstellung und diese enthaltende pharmazeutische praeparate. ATE2898T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7830952 1978-07-25
EP79200416A EP0007678B1 (de) 1978-07-25 1979-07-24 Oxim-Äther, ihre Herstellung und diese enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ATE2898T1 true ATE2898T1 (de) 1983-04-15

Family

ID=10498633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79200416T ATE2898T1 (de) 1978-07-25 1979-07-24 Oxim-aether, ihre herstellung und diese enthaltende pharmazeutische praeparate.

Country Status (12)

Country Link
US (1) US4352804A (de)
EP (1) EP0007678B1 (de)
JP (1) JPS5519287A (de)
AT (1) ATE2898T1 (de)
AU (1) AU4890079A (de)
CA (1) CA1127169A (de)
DE (1) DE2965108D1 (de)
DK (1) DK312479A (de)
IL (1) IL57810A0 (de)
NO (1) NO792445L (de)
NZ (1) NZ191092A (de)
ZA (1) ZA793642B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347372A (en) * 1978-09-01 1982-08-31 Ciba-Geigy Corporation Benzoxazolyl-glyoxylonitrile-2-oxime ether derivatives
CA1225092A (en) * 1980-10-10 1987-08-04 Franz Dorn Pyridine and pyrazine derivatives
DE3219041A1 (de) * 1982-05-19 1983-11-24 Bayer Ag, 5090 Leverkusen 1-azolyl-2-oximino-butan-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und pflanzenwachstumsregulatoren
IT1155358B (it) * 1982-07-06 1987-01-28 Vetem Spa Derivati chinazolinonici attivi contro la coccidiosi
JPS6463574A (en) * 1987-09-03 1989-03-09 Mitsubishi Chem Ind Ethanone oximes
GB8726109D0 (en) * 1987-11-06 1987-12-09 Shell Int Research Imidazole oxime derivatives
JP2765876B2 (ja) * 1988-10-24 1998-06-18 科研製薬株式会社 ピリジルケトオキシムエーテル誘導体
CA2014880A1 (en) * 1989-04-27 1990-10-27 Indu Sawhney Thiazole derivatives
IL97144A (en) * 1990-02-27 1994-11-28 Erba Carlo Spa Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives, their preparation and pharmaceutical compositions containing them
ES2130269T3 (es) * 1992-06-17 1999-07-01 Upjohn Co Oximas sustituidas con piridina, pirrolidina y azepina utiles como agentes contra la aterosclerosis y antihipercolesterolemicos.
KR100191137B1 (ko) * 1992-07-21 1999-06-15 사노 가즈오 옥심 유도체
GB9315058D0 (en) * 1993-07-20 1993-09-01 Erba Carlo Spa 2-(imidazol-1-yl)benzylethylidene-aminooxylkyl-hydroxamic acid derivatives
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
BRPI0716680A2 (pt) 2006-11-02 2013-09-24 Daniel J Capon "composto, multÍmero, composiÇço, mÉtodo de afetar a atividade de um alvo, complexo, processo de produÇço do composto, mÉtodo de produÇço de um extensço de aminoÁcidos consecutivos, processo de produÇço de uma extensço de aminoacidos consecutivos , processo para a produÇço de um composto , mÉtodo de produÇço de uma proteina e polipeptÍdeo"
CN102690246B (zh) * 2012-05-30 2014-06-04 华中农业大学 肟醚胺类化合物或其盐、包含肟醚胺类化合物或其盐的组合物及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3205234A (en) * 1961-06-30 1965-09-07 Upjohn Co Nu-oxides of pyridyl ketone omicron-hydrocarbonoximes
OA02732A (fr) 1967-05-13 1968-12-15 Fisons Pest Control Ltd Pesticides.
US3957805A (en) * 1974-07-24 1976-05-18 American Cyanamid Company Substituted pyridines and diazines and methods of preparing the same
GB1600969A (en) 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds

Also Published As

Publication number Publication date
EP0007678A1 (de) 1980-02-06
NO792445L (no) 1980-01-28
JPS5519287A (en) 1980-02-09
AU4890079A (en) 1980-01-31
EP0007678B1 (de) 1983-03-30
ZA793642B (en) 1980-07-30
CA1127169A (en) 1982-07-06
DE2965108D1 (en) 1983-05-05
DK312479A (da) 1980-01-26
IL57810A0 (en) 1979-11-30
US4352804A (en) 1982-10-05
NZ191092A (en) 1982-03-09

Similar Documents

Publication Publication Date Title
ATE2898T1 (de) Oxim-aether, ihre herstellung und diese enthaltende pharmazeutische praeparate.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
SE8700499D0 (sv) Novel pharmacologically active compounds
DE59009074D1 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus.
SE7712693L (sv) Organiska foreningar
IE38730B1 (en) Heterocyclic containing sulphoxides
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
JPS5412372A (en) Thiazolidine derivative and its preparation
IL57577A (en) 1,2-dihydroquinolin-2-one derivatives,processes for their preparation and pharmaceutical compositions containing the same
EP0091749A3 (de) Ethanolamin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
NL177689C (nl) Farmaceutisch preparaat voor het behandelen van gevolgen van diabetes, alsmede imidazolidine-2,5-dion-spiro-(zesledige ring)-verbinding.
DK324185D0 (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
ATE11915T1 (de) Benzothiazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
NO159854C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive beta-karbolin-3-karboksylsyrederivater.
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
SE8303719L (sv) Eburnan-oximderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar
ATE5480T1 (de) Thiazolo(3,2-a)pyrimidinderivate, ihre herstellung und arzneimittel, die diese derivate enthalten.
ATE123497T1 (de) Substituierte pyridin-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
JPS5285175A (en) Amino-substituted propiophenone derivatives and medicaments containing same
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
SU1154907A1 (ru) Дигидрохлорид 3-(2-диэтиламиноэтилтио)-5-(2-морфолиноэтил)-1,2,4-триазино(5,6-в)индола, обладающий стресспротективной активностью
JPS5271473A (en) Thiapyranyl thiophosphates insecticide and miticide
JPS5384991A (en) Novel nitrogen-containing heterocyclic compound and its preparation
IT1190660B (it) Composto ad attivita' mucoregolatrice e antitosse,procedimento per la sua preparazione e relative composizioni farmaceutiche